Announcements Trials

Browse Landscape

Phase

Phase 2 103 Phase 1 26 Phase 1/2 9 Phase 4 3 Phase NA 2 Phase EARLY_PHASE1 1 Phase 3 1

Status

Sponsor Class

INDUSTRY 19 NIH 3 NETWORK 2 OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Kidney Neoplasms 1 Carcinoma, Renal Cell 1

Interventions

Cisplatin 294 Radiotherapy 230 Fluorouracil 201 Cyclophosphamide 191 Capecitabine 182 Docetaxel 166 Gemcitabine 165 Oxaliplatin 162 Carboplatin 160 Paclitaxel 152 Leucovorin 122 Drug Therapy 118 Dexamethasone 118 Doxorubicin 112 Etoposide 99 Bevacizumab 91 Cytarabine 87 Vincristine 83 Irinotecan 81 Rituximab 77 Epirubicin 71 Prednisone 65 Radiosurgery 63 Methotrexate 62 Surgical Procedures, Operative 61 Radiation 60 Radiotherapy, Intensity-Modulated 56 Neoadjuvant Therapy 53 Lenalidomide 52 Letrozole 50

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × OTHER × cabozantinib × Clear all

NCT06364631 2025-01-16

CARE1

Gustave Roussy, Cancer Campus, Grand Paris

Phase 3 Recruiting

Carcinoma, Renal Cell, Kidney Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡